Hygiene-Institute, University of Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany.
Eur J Clin Microbiol Infect Dis. 2010 May;29(5):563-70. doi: 10.1007/s10096-010-0896-0. Epub 2010 Mar 7.
We report the first outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. The presence of KPC was confirmed by polymerase chain reaction (PCR). The KPC-encoding plasmid was analysed by transconjugation experiments, DNA sequencing, Southern blotting and isoelectric focussing. Typing was performed by pulsed-field gel electrophoresis (PFGE). An ertapenem-resistant K. pneumoniae with low minimum inhibitory concentrations (MIC) to other cabapenems (tested by the Vitek system) was isolated from the index patient in January 2008. A KPC-2 was identified after K. pneumoniae with identical susceptibility patterns had been isolated from two more patients. Despite the introduction of infection control measures, transmission occurred in five additional patients and three of the patients died from infections. The source of the outbreak strain remained unclear; however, the Tn4401-containing bla (KPC-2) gene was similar to previously described isolates from Greece. Five months after the end of the outbreak, a KPC-K. pneumoniae was isolated from a patient who had been treated in Greece previously. Retrospectively, this patient was treated in November 2007 on the same unit as the index case. Typing revealed that all patients were colonised by the same strain. KPC-K. pneumoniae has been introduced to Germany possibly from Greece and transmission to other institutions is likely.
我们报告了德国首例产碳青霉烯酶肺炎克雷伯菌(KPC)的爆发。通过聚合酶链反应(PCR)确认了 KPC 的存在。通过转导实验、DNA 测序、Southern 印迹和等电聚焦分析了 KPC 编码质粒。通过脉冲场凝胶电泳(PFGE)进行了分型。2008 年 1 月,从一名指数患者中分离出了一株对厄他培南耐药的肺炎克雷伯菌,其对其他碳青霉烯类药物的最小抑菌浓度(MIC)较低(通过 Vitek 系统检测)。在从另外两名患者中分离出具有相同药敏模式的 KPC-2 后,鉴定出了一种 KPC-2。尽管采取了感染控制措施,但仍在另外 5 名患者中发生了传播,其中 3 名患者死于感染。暴发菌株的来源仍不清楚;然而,含有 bla(KPC-2)基因的 Tn4401 与之前描述的来自希腊的分离株相似。暴发结束五个月后,从一名曾在希腊接受治疗的患者中分离出了一株产 KPC 的肺炎克雷伯菌。回顾性分析显示,所有患者均被同一株定植。KPC-肺炎克雷伯菌可能是从希腊传入德国的,并且可能已传播到其他医疗机构。